![Nicholas Edward John West](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nicholas Edward John West
Hoofd Techniek/Wetenschap/O&O bij SHOCKWAVE MEDICAL
Actieve functies van Nicholas Edward John West
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SHOCKWAVE MEDICAL | Hoofd Techniek/Wetenschap/O&O | - | - |
PlaqueTec Ltd.
![]() PlaqueTec Ltd. Miscellaneous Commercial ServicesCommercial Services PlaqueTec Ltd. develops a liquid biopsy system platform technology that provides unparalleled resolution of the biological processes that cause coronary artery disease. The firm’s Liquid Biopsy System addresses the underlying biomarker collection problems preventing advances in CAD research. The company was founded by Stephen Blatcher in 2000 and is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | - | - |
Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Nicholas Edward John West
Statistieken
Internationaal
Verenigd Koninkrijk | 2 |
Verenigde Staten | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 1 |
Sectoraal
Commercial Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
PlaqueTec Ltd.
![]() PlaqueTec Ltd. Miscellaneous Commercial ServicesCommercial Services PlaqueTec Ltd. develops a liquid biopsy system platform technology that provides unparalleled resolution of the biological processes that cause coronary artery disease. The firm’s Liquid Biopsy System addresses the underlying biomarker collection problems preventing advances in CAD research. The company was founded by Stephen Blatcher in 2000 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Shockwave Medical, Inc.
![]() Shockwave Medical, Inc. Medical SpecialtiesHealth Technology Shockwave Medical, Inc. operates as a medical device company, which concentrates on developing and commercializing products intended to transform the way classified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA. | Health Technology |